This article contains paid contributions. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (October 2026) |
Frederick R. Maxfield | |
|---|---|
| Education | Union College (BS) Cornell University (PhD) |
| Known for | Endocytosis, intracellular cholesterol transport, cellular membrane trafficking |
| Awards | NIH MERIT Award Highly Cited Researcher |
Frederick R. Maxfield is an American biochemist and the Vladimir and Wanda Toscanini Horowitz Distinguished Professor in the Department of Biochemistry at Weill Cornell Medicine. He is recognized for his pioneer work on cellular membrane trafficking, endocytosis, and intracellular cholesterol transport.
Maxfield completed his Bachelor of Science in chemistry at Union College in June 1971. He earned his PhD in biophysical chemistry from Cornell University in May 1977 under the supervision of Harold A. Scheraga. From August 1977 to December 1979, he was a postdoctoral fellow in the Laboratory of Molecular Biology at the National Cancer Institute under Ira Pastan.
In 1979, Maxfield joined the faculty at the New York University School of Medicine as an Assistant Professor of Pharmacology, later rising to Professor. He moved to Columbia University Irving Medical Center in 1987 as Professor of Pathology and Physiology. In 1995, he was appointed Vladimir and Wanda Toscanini Horowitz Professor and Chair of Biochemistry at Weill Cornell Medical College, a department leadership role he held until 2021. He also served as Interim Chair of Cell and Developmental Biology at Weill Cornell from 2014 till 2021.
The Maxfield laboratory utilizes quantitative biological and physical methods, including fluorescence microscopy, to analyze dynamic processes in living cells. Early investigations focused on measuring endosomal pH levels, mapping endocytic pathways, and characterizing intracellular cholesterol transport mechanisms.
His research focuses on cellular lipid transport, endocytosis, and neurodegenerative diseases. His laboratory identified digestive exophagy; a process where macrophages degrade aggregated low-density lipoproteins (LDL) extracellularly, contributing to foam cell formation in atherosclerosis. His team also studied intracellular cholesterol transport via STARD4, microglial degradation of amyloid beta in Alzheimer's disease, and experimental treatments for Niemann–Pick disease, type C.
Notable former lab members include physician-scientist Peter Marks, who completed his Ph.D. under Maxfield's supervision.
Maxfield has served as President of the Harvey Society and the New York Society for Experimental Microscopy. In 2020, he was elected a Fellow of the American Society for Cell Biology.
In 2019, he received Fletcher McDowell Award from Burke Neurological Institute.
Maxfield has authored or co-authored nearly 270 peer-reviewed scientific publications. Notable papers include: